MAPFRE Life Insurance Company
Medicare | HMO | www.mapfrelife.com
| States: | |
| Rank: | - |
| Score: | No score—insufficient data |
| NCQA Accredited: | No |
How This Plan Performed (methodology)
Prevention I
| Breast cancer screening | NA |
| Colorectal cancer screening | NA |
| Glaucoma screening | NA |
| Mental health status | NR |
| Physical health status | NR |
Treatment I
| Diabetes | 1 |
|---|---|
| Retinal eye exams | 1 |
| Glucose testing | 1 |
| Glucose control | 1 |
| LDL cholesterol screening | 1 |
| LDL cholesterol control | 1 |
| Monitoring kidney disease | 3 |
| Heart disease | I |
| Giving beta blocker after heart attack | NA |
| Staying on beta blocker after heart attack | NA |
| Controlling high blood pressure | NA |
| LDL cholesterol screening | NA |
| LDL cholesterol control | NA |
| Mental and behavioral health | I |
| Depression—appropriate follow-up after diagnosis | NA |
| Depresssion—adhering to medication for 12 weeks | NA |
| Depresssion—adhering to medication for six months | NA |
| Follow-up after hospitalization for mental illness | NA |
| Alcohol or drug dependence treatment initiated | NR |
| Alcohol or drug dependence treated for 30 days | NR |
| Other treatment measures | |
| Medication for rheumatoid arthritis | NA |
| Monitoring of key long-term medications | 1 |
| Spirometry testing for COPD | NA |
| Managing osteoporosis in women after a fracture | NA |
| Discussing and treating urinary incontinence | NR |
| Avoiding high-risk medications | 1 |
I = Insufficient Data; NA = Not applicable; NR = Not reported
Note: Apparent ties are due to rounding. Accreditation status is as of July 31, 2007.
In association with NCQA.
